在NIR指导下优化Omega-3脂肪酸迷你软囊的涂层,使用Pitavastatin和Ezetimibe
Hye-Ri Han1, Ji Hoon Choi1,2, Je Hwa Yoo1,3
1Department of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Pharmaceutics
|November 27, 2024
概括
近红外 (NIR) 光谱优化欧米茄-3脂肪酸 (OM3-FA) 迷你软囊涂层用于皮塔瓦斯塔丁和埃泽蒂米布. 这一过程确保了稳定性和机械完整性,改善了心血管疾病治疗的坚持.
科学领域:
- 制药技术 制药技术 制药技术
- 过程分析技术 (PAT) 是一种分析技术.
背景情况:
- 在迷你软囊中配制欧米茄-3脂肪酸 (OM3-FA) 与皮塔瓦斯塔丁和埃泽蒂米布,这就给稳定性和完整性带来了挑战.
- 心血管疾病的治疗受益于OM3-FA和降脂剂的组合.
研究的目的:
- 为了优化OM3-FA含有皮塔瓦斯塔丁和ezetimibe的迷你软囊的涂层过程.
- 实施近红外 (NIR) 光谱技术,用于工艺中的监测和质量控制.
主要方法:
- 使用带有实时NIR监控的面膜涂层器进行涂层均性的监测.
- 采用NIR光谱仪来精确控制涂层厚度和药物分布.
主要成果:
- 将OM3-FA氧化最小化并保持囊的机械完整性.
- 通过体外溶解和纹理分析证实了皮塔瓦斯塔丁-埃泽蒂米布组合的稳定性和有效性.
- 通过使用NIR光谱作为过程分析技术 (PAT) 证明了改进的涂层质量控制.
结论:
- 使用NIR-PAT优化涂层过程产生稳定的迷你软囊,用于心血管治疗.
- 尼尔光谱为制药制造提供了一种多功能工具,提高产品质量和生产效率.
- 这种方法支持连续制造和自动化质量保证,以简化药品生产.
更多相关视频
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.6K
13:54A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
Published on: August 18, 2023
4.4K
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
536
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
536
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
177
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
177
